Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Kansas Medical Center
About this trial
PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Eligibility criteria
Qualifiers
ER/PR <10% and HER negative per current ASCO/CAP guidelines
Stages I-IV
Any age at diagnosis
Patient must be within 5 years of diagnosis
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,500 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of Kansas Medical Center
Lead sponsor
University of Kansas
Sponsor institution
Source ClinicalTrials.gov